RxDoctor Payments Data

Daman Singh, MD

Hospitalist · Doylestown, PANPI 1659821601

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 27.8% of the total. Reporting peaked in 2024 at $913 and has fallen 79.2% since, to $190 in 2025. Among hospitalist clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,124in general payments, 2019–2025

Across 167 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$870
  • E.r. Squibb & Sons, L.L.C.$662
  • AstraZeneca$466
  • AbbVie$207
  • Pfizer$158
  • La Jolla Pharmaceutical Company$136
  • plus $626 from 12 others

What the payments were for

  • Food & beverage$3,124100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,124 in reported general payments places this provider in the 95th percentile of 1,287 hospitalist providers in Pennsylvania.

See all hospitalist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$152,908
Medicare patients
413
Services billed
1,448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Midodrine Hcl14$317
Pantoprazole Sodium44$308
Metoprolol Succinate26$266
Cefdinir30$263
Doxycycline Hyclate13$225
Albuterol Sulfate HfaAlbuterol Sulfate11$222
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$169
Diltiazem 24hr Er (Cd)Diltiazem Hcl13$133
Losartan Potassium11$115
Prednisone23$88
Atorvastatin Calcium11$71
Furosemide29$63
Amlodipine Besylate12$37

Paid to pharmacies, not to this prescriber.

Other hospitalist in Doylestown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →